75N93020C00038↗

Name: 75N93020C00038: To Develop Innovative and Safe Multivalent Anti-Opioid Vaccines That Protect Against Heroin and Fentanyl.
Creator: SpendQuery

TO DEVELOP INNOVATIVE AND SAFE MULTIVALENT ANTI-OPIOID VACCINES THAT PROTECT AGAINST HEROIN AND FENTANYL.

Definitive Contract · National Institutes of Health · to Children'S Hospital Corporation, the (UEI Z1L9F1MM1RY3) · data as of 2026-09-30

Obligated to date$6.21M6 actions

Current value$19.89Mwith options exercised

Potential value$24.79Mif every option is used

Period2020-09-30 → 2027-09-29current end date

Up for re-bid: ends 2027-09-29. Recompete brief → · Statistical and Data Coordinating Center (SDCC) for Clinical Research in Infectious Diseases (CRID) ↗

What it is

Product or service: Health R&D Services; Health Care Services; Applied Research (PSC AN12)
Industry: Research and Development in Biotechnology (Except Nanobiotechnology) (NAICS 541714)
Contracting office: National Institutes of Health Niaid (75N930)
Competition: Full and open competition · 9 offers received
Pricing: Cost no fee
How it was bought: Standalone contract
Solicitation: BAA-DAIT-75N93019R009
Where the work is: Suffolk, MA · district MA-07
Topics: opioids

Obligations by fiscal year

FY2023$6.21M

FY2024$0

FY2025$0

FY2026$0

SpendQuery holds FY2023 on; earlier years are on USAspending.gov.

Subcontractors: where the money went next

No subawards reported for this award. Primes report subawards of $30,000 or more; many awards have none.

Every action

6 actions since 2023-08-03. Each is a modification or amendment with the money it added or took back.

Date	Modification	Kind	Amount	What the agency wrote
2026-07-10	P00011	Administrative change	$0	EO14398 TO DEVELOP INNOVATIVE AND SAFE MULTIVALENT ANTI-OPIOID VACCINES THAT PROTECT AGAINST HEROIN AND FENTANYL.
2025-06-26	P00010	Administrative change	$0	TO DEVELOP INNOVATIVE AND SAFE MULTIVALENT ANTI-OPIOID VACCINES THAT PROTECT AGAINST HEROIN AND FENTANYL.
2024-09-24	P00009	Administrative change	$0	TO DEVELOP INNOVATIVE AND SAFE MULTIVALENT ANTI-OPIOID VACCINES THAT PROTECT AGAINST HEROIN AND FENTANYL.
2024-08-23	P00008	Administrative change	$0	TO DEVELOP INNOVATIVE AND SAFE MULTIVALENT ANTI-OPIOID VACCINES THAT PROTECT AGAINST HEROIN AND FENTANYL.
2023-08-30	P00007	Administrative change	$0	TO DEVELOP INNOVATIVE AND SAFE MULTIVALENT ANTI-OPIOID VACCINES THAT PROTECT AGAINST HEROIN AND FENTANYL.
2023-08-03	P00006	Option exercised	$6.21M	TO DEVELOP INNOVATIVE AND SAFE MULTIVALENT ANTI-OPIOID VACCINES THAT PROTECT AGAINST HEROIN AND FENTANYL.

Source: USAspending.gov prime award transactions and FSRS subaward reports, as loaded by SpendQuery (data as of 2026-09-30). Amounts are obligations (money committed), not outlays. The official record on USAspending.gov ↗